Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Kezar Life Sciences, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −1 vs. Q2 2025
- Shares held
- 4.24M
- −235.2K (−5.3%) vs. Q2 2025
- Total value
- $16.5M
- −$3.96M (−19.3%) vs. Q2 2025
- New holders
- 3
- 9 more added
- Sold out
- 4
- 8 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 720,787 | $2.81M | 2.59% | +85,604+13.5% | Added |
| Tang Capital Management LLC | 720,000 | $2.81M | 0.11% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 716,759 | $2.80M | 0.08% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 383,182 | $1.49M | 1.21% | +213,323+125.6% | Added |
| Vanguard Group Inc | 268,166 | $1.05M | 0.00% | −8,062−2.9% | Reduced |
| OrbiMed Advisors LLC | 192,700 | $751.5K | 0.02% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 133,525 | $519.0K | 0.00% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 125,773 | $490.5K | 0.44% | +10,650+9.3% | Added |
| ADAR1 Capital Management, LLC | 124,967 | $487.4K | 0.05% | −22,437−15.2% | Reduced |
| Renaissance Technologies LLC | 115,885 | $452.0K | 0.00% | +28,601+32.8% | Added |
| Ikarian Capital, LLC | 106,901 | $416.9K | 0.09% | 00.0% | Unchanged |
| BlackRock, Inc. | 98,103 | $382.6K | 0.00% | +432+0.4% | Added |
| Qiming U.S. Ventures Management, LLC | 82,871 | $323.2K | 0.58% | 00.0% | Unchanged |
| Shay Capital LLC | 67,661 | $263.9K | 0.05% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 65,502 | $255.5K | 0.00% | +383+0.6% | Added |
| Two Sigma Advisers, LP | 54,261 | $211.6K | 0.00% | −380−0.7% | Reduced |
| Bridgeway Capital Management, LLC | 41,000 | $159.9K | 0.00% | 00.0% | Unchanged |
| Bluefin Capital Management, LLC | 33,610 | $131.1K | 0.06% | +33,610 | New |
| RBF Capital, LLC | 28,253 | $110.2K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 23,682 | $92.4K | 0.00% | −1,201−4.8% | Reduced |
| Dimensional Fund Advisors LP | 23,231 | $90.6K | 0.00% | −6,739−22.5% | Reduced |
| State Street Corp | 21,093 | $82.3K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 20,900 | $81.5K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 18,221 | $71.1K | 0.00% | +18,221 | New |
| Northern Trust Corp | 13,940 | $54.4K | 0.00% | 00.0% | Unchanged |
| Landscape Capital Management, L.L.C. | 13,042 | $50.9K | 0.00% | +13,042 | New |
| FMR LLC | 8,732 | $34.1K | 0.00% | −13,933−61.5% | Reduced |
| Morgan Stanley | 7,820 | $30.5K | 0.00% | −873−10.0% | Reduced |
| Wells Fargo & Company | 5,846 | $22.8K | 0.00% | +100+1.7% | Added |
| Tower Research Capital LLC (TRC) | 1,187 | $4.63K | 0.00% | +1,042+718.6% | Added |
| Global Retirement Partners, LLC | 1,000 | $3.90K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 356 | $1.39K | 0.00% | +315+768.3% | Added |
| JPMorgan Chase & Co | 209 | $815 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 121 | $472 | 0.00% | −59−32.8% | Reduced |
| CIBC Private Wealth Group, LLC | 100 | $390 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 96 | $374 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 90 | $323 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 51 | $199 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −502,600−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −58,539−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −25,677−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |